Your browser doesn't support javascript.
loading
Common practical questions - and answers - at the British Association for Psychopharmacology child and adolescent psychopharmacology course.
Cortese, Samuele; Besag, Frank Mc; Clark, Bruce; Hollis, Chris; Kilgariff, Joseph; Moreno, Carmen; Nicholls, Dasha; Wilkinson, Paul; Woodbury-Smith, Marc; Sharma, Aditya.
Afiliação
  • Cortese S; Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK.
  • Besag FM; Solent NHS Trust, Southampton, UK.
  • Clark B; Hassenfeld Children's Hospital at NYU Langone, New York University Child Study Center, New York City, NY, USA.
  • Hollis C; Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, UK.
  • Kilgariff J; UCL School of Pharmacy, London, UK.
  • Moreno C; East London Foundation NHS Trust, Bedfordshire, UK.
  • Nicholls D; Institute of Psychiatry, Psychology and Neuroscience, KCL, London, UK.
  • Wilkinson P; National Specialist Clinic for Young People with OCD, BDD and Related Disorders, South London and Maudsley NHS Foundation Trust, London, UK.
  • Woodbury-Smith M; Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, UK.
  • Sharma A; Department of Child and Adolescent Psychiatry, Nottinghamshire Healthcare NHS Foundation Trust, Queen's Medical Centre, Nottingham, UK.
J Psychopharmacol ; 37(2): 119-134, 2023 02.
Article em En | MEDLINE | ID: mdl-36476096
The British Association for Psychopharmacology course on child and adolescent psychopharmacology has been run for more than 20 years and is currently a very popular course, attracting around 140 delegates/year from across the United Kingdom and abroad. As Faculty of recent sessions of the course, we have selected the most common questions we have been asked in recent years and provided evidence-based and/or expert-informed answers. We have included 27 questions and answers related to attention-deficit/hyperactivity disorder, anxiety and depressive disorders, autism spectrum disorder, bipolar disorder, eating disorders, epilepsy (in differential diagnosis or comorbid with mental health conditions), obsessive-compulsive disorder, personality disorders, psychotic spectrum disorders, and tics/Tourette syndrome in children and young people. We hope that this article will be helpful for prescribers in their daily clinical practice and we look forward to further, high-level evidence informing the answers to these and other questions in child and adolescent psychopharmacology.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psicofarmacologia / Psicotrópicos / Transtornos Mentais Tipo de estudo: Risk_factors_studies Limite: Adolescent / Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psicofarmacologia / Psicotrópicos / Transtornos Mentais Tipo de estudo: Risk_factors_studies Limite: Adolescent / Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article